SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement
Stopped early · Not applicable
Conditions studied: Blood Pressure (Low, Normal, High)
In brief
The primary objective of this study is to show that the noninvasive blood pressure software algorithm meets engineering requirements.
Key facts
- Study ID
- NCT01482325
- Run by
- GE Healthcare
- People needed
- 31
- Starts
- 2011-11-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2016-09-30
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Ability to provide written informed consent or have a legally authorized representative including a parent or guardian provide written informed consent
- Ability of a minor subject ages 7 to 18 to provide written assent
- Ability to have multiple noninvasive blood pressures taken at one sitting
- Ability to apply three lead ECG, if needed for investigation
- Ability to detect the natural presence of an irregular pulse, for irregular pulse studies
You may not qualify if…
- Any subject who cannot tolerate multiple blood pressure measurements
- Any subject who cannot undergo 3-lead ECG, if needed
- Any subject deemed unstable by the principal investigator
- Any subject for whom precautions are necessary because of communicable disease
- Any subject that has a known disease or condition compromises musculoskeletal integrity
- Any subject that has a known disease or condition that contraindicates use of an NIBP cuff and ECG patches on the skin.
Where it is running
- St. Josephs Hospital — Milwaukee, Wisconsin, United States
- Wisconsin Heart Hospital — Wauwatosa, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.